ICON Public Limited Company
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, manage…
Medical - Diagnostics & Research
IE, Dublin [HQ]
Ratios
15 Sheets · Starting from 2023Margins, Growth Rates In %
| Ratio | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||
| Gross Margin | 42.79 | 39.85 | 35.30 | 35.59 | 36.72 | 39.92 | 42.29 | 42.31 | 41.34 | 29.64 | 29.64 | 28.89 | 27.52 | 28.60 | 22.34 | |
| Profit Margin | 10.62 | 9.67 | 2.42 | 5.23 | 7.70 | 11.47 | 15.21 | 15.73 | 15.52 | 12.44 | 13.33 | 11.72 | 2.79 | 6.53 | 7.54 | |
| Operating Margin | 12.11 | 10.23 | 3.11 | 6.24 | 9.07 | 13.46 | 17.88 | 18.70 | 18.88 | 14.53 | 15.45 | 14.01 | 11.10 | 10.27 | 13.04 | |
|
EPS Growth
|
20.15 | -9.32 | -73.97 | 155.26 | 74.23 | 65.68 | 45.71 | 16.42 | 6.11 | 18.25 | 16.44 | -9.37 | -63.75 | 171.93 | 20.32 | |
| EPS USD | 161.00 | 146.00 | 38.00 | 97.00 | 169.00 | 280.00 | 408.00 | 475.00 | 504.00 | 596.00 | 694.00 | 629.00 | 228.00 | 620.00 | 746.00 | |
| Return on Assets (ROA) | 10.38 | 9.17 | 2.21 | 4.84 | 7.13 | 11.29 | 13.94 | 14.36 | 12.49 | 13.53 | 12.86 | 9.46 | 0.88 | 2.94 | 3.60 | |
| Return on Equity (ROE) | 16.48 | 13.00 | 3.36 | 7.61 | 11.29 | 18.15 | 31.35 | 27.74 | 22.19 | 23.28 | 23.11 | 17.43 | 1.90 | 5.95 | 6.63 | |
| Return on Invested Capital (ROIC) | 16.92 | 12.91 | 3.41 | 6.14 | 11.13 | 17.71 | 27.63 | 24.88 | 15.06 | 15.96 | 18.41 | 14.69 | 3.52 | 5.36 | 7.96 | |
| Solvency | ||||||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | - - | - - | - - | 16.26 | 1.05 | 1.44 | 6.46 | 8.17 | 27.71 | 28.68 | 15.63 | 12.51 | 32.18 | 27.85 | 22.44 | |
| Debt/Equity | - - | - - | - - | 25.58 | 1.66 | 2.32 | 14.54 | 15.77 | 49.24 | 49.37 | 28.09 | 23.06 | 69.37 | 56.32 | 41.25 | |
| Debt/EBITDA | -102.58 | -202.83 | -135.87 | -100.48 | -98.26 | -43.64 | 72.55 | 40.24 | 19.42 | -10.42 | -13.29 | -83.19 | 524.51 | 312.75 | 211.15 | |
|
Debt/Capitalization
|
- - | - - | - - | 20.37 | 1.63 | 2.27 | 12.69 | 13.62 | 32.99 | 33.05 | 21.93 | 18.74 | 40.96 | 36.03 | 29.20 | |
| Long-Term Debt/Capitalization | - - | - - | - - | 0.96 | 18.83 | 22.50 | 31.41 | 26.94 | 22.09 | 20.12 | 4.52 | 17.87 | 40.72 | 35.76 | 28.40 | |
| Interest Debt per Share USD | 0.06 | 0.02 | 0.03 | 3.30 | 0.27 | 0.37 | 1.96 | 2.93 | 11.43 | 12.90 | 8.56 | 8.49 | 86.10 | 61.52 | 50.53 | |
| Debt Growth | -99.72 | -33.33 | -100.00 | - - | - - | - - | - - | -0.43 | 0.11 | 0.11 | 30.15 | -4.61 | 1,190.51 | -14.48 | -17.71 | |
| Liquidity | ||||||||||||||||
| Current Ratio | 178.76 | 231.57 | 333.15 | 154.42 | 287.01 | 292.58 | 271.24 | 351.21 | 191.49 | 213.95 | 143.64 | 185.69 | 118.65 | 120.01 | 120.73 | |
| Quick Ratio | 138.09 | 168.03 | 249.03 | 149.35 | 269.09 | 273.59 | 259.37 | 338.32 | 186.15 | 208.82 | 139.97 | 181.54 | 114.04 | 114.92 | 116.06 | |
| Cash Ratio | 48.34 | 102.15 | 79.07 | 27.22 | 61.38 | 42.45 | 32.60 | 70.59 | 48.69 | 63.02 | 45.99 | 73.81 | 30.34 | 10.73 | 13.38 | |
| Operating Cash Flow Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Turnover | ||||||||||||||||
| Inventory Turnover | - - | 939.39 | -351.32 | 24,244.90 | 2,951.45 | 3,654.18 | - - | - - | 46,130.41 | 80,311.65 | 61,691.72 | 41,391.09 | - - | 78,253.50 | - - | |
| Receivables Turnover | 404.26 | 545.79 | 469.72 | 256.07 | 278.76 | 273.17 | 247.36 | 251.66 | 243.90 | 303.25 | 276.84 | 228.39 | 264.40 | 276.33 | 280.07 | |
| Payables Turnover | 286.36 | 4,396.52 | 11,459.23 | 8,812.54 | 18,402.55 | 32,336.81 | 12,946.58 | 11,054.89 | 5,548.55 | 13,743.88 | 8,208.46 | 3,891.88 | 4,376.86 | 6,807.21 | 4,792.30 | |
|
Asset Turnover
|
97.71 | 94.79 | 91.33 | 92.52 | 92.62 | 98.40 | 91.63 | 91.27 | 80.45 | 108.78 | 96.50 | 80.71 | 31.52 | 45.05 | 47.79 | |
| Fixed Turnover | 495.90 | 526.77 | 561.39 | 888.96 | 830.73 | 1,014.49 | 1,048.46 | 1,118.70 | 1,673.11 | 2,502.92 | 1,038.95 | 1,450.06 | 1,025.28 | 1,535.53 | 1,619.12 | |
| Coverage | ||||||||||||||||
| Interest Coverage | 3,043.97 | 8,135.60 | 1,793.12 | 3,527.84 | 9,407.38 | 25,777.07 | 7,052.51 | 2,396.54 | 2,554.61 | 2,770.28 | 6,754.03 | 2,600.29 | 333.55 | 346.16 | 314.42 | |
| Asset Coverage | 199,600 | 345,400 | - - | - - | - - | - - | 300 | 300 | 400 | 500 | 400 | 500 | 100 | 200 | 200 | |
| Cash Flow Coverage (CFGR) | - - | - - | - - | 58.04 | 1,462.56 | 770.46 | 251.60 | 173.86 | 8.05 | 38.57 | 90.76 | 137.16 | 14.82 | 11.77 | 30.46 | |
| EBITDA Coverage | 3,900 | 11,100 | 5,300 | 5,700 | 14,400 | 34,700 | 8,400 | 2,900 | 2,600 | 3,200 | 7,700 | 3,200 | 500 | 600 | 500 | |
| Dividend Coverage | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 200 | 100 | 100 | 100 | 200 | |
| Market Prospects | ||||||||||||||||
| Dividend Yield | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Earnings Yield | 7.40 | 6.66 | 2.22 | 3.51 | 4.18 | 5.50 | 5.25 | 6.31 | 4.41 | 4.62 | 4.03 | 3.18 | 0.74 | 3.19 | 2.64 | |
|
Price/Earnings (P/E)
|
1,351.21 | 1,502.04 | 4,515.26 | 2,853.18 | 2,394.30 | 1,818.13 | 1,905.59 | 1,584.69 | 2,270.33 | 2,166.15 | 2,480.37 | 3,144.09 | 13,567.92 | 3,134.28 | 3,795.40 | |
| Price/Earnings Growth (PEG) | 67.06 | -161.22 | -61.04 | 18.38 | 32.26 | 27.68 | 41.68 | 96.50 | 371.86 | 118.67 | 150.85 | -335.69 | -212.82 | 18.23 | 186.76 | |
|
Price/Book (P/B)
|
222.66 | 195.20 | 151.58 | 217.20 | 270.34 | 330.00 | 597.31 | 439.57 | 503.70 | 504.38 | 573.29 | 548.03 | 257.65 | 186.37 | 251.50 | |
| Price/Tangible Book (P/TB) | 222.66 | 195.20 | 151.58 | 217.20 | 270.34 | 330.00 | 597.31 | 439.57 | 503.70 | 504.38 | 573.29 | 548.03 | 257.65 | 186.37 | 251.50 | |
| Price/Sales (P/S) | 143.55 | 145.31 | 109.24 | 149.30 | 184.25 | 208.58 | 289.82 | 249.31 | 352.40 | 269.39 | 330.60 | 368.45 | 379.21 | 204.58 | 286.21 | |
|
Price/Cash Flow (P/CF)
|
499.54 | 1,495.91 | 5,116.59 | 1,463.22 | 1,112.72 | 1,845.09 | 1,632.96 | 1,602.88 | 12,713.60 | 2,648.61 | 2,248.56 | 1,733.01 | 2,506.69 | 2,811.51 | 2,001.72 | |
| Price/Free CF (P/FCF) | 575.83 | 2,315.75 | -6,844.83 | 2,006.17 | 1,283.84 | 2,286.00 | 1,986.34 | 1,918.13 | 12,720.91 | 3,243.12 | 2,563.23 | 1,895.75 | 2,826.25 | 3,760.53 | 2,277.74 | |
| Price/Operating CF (P/OCF) | 499.54 | 1,495.91 | 5,116.59 | 1,463.22 | 1,112.72 | 1,845.09 | 1,632.96 | 1,602.88 | 12,713.60 | 2,648.61 | 2,248.56 | 1,733.01 | 2,506.69 | 2,811.51 | 2,001.72 |